FDA approves Symjepi (epinephrine Injection pre-filled single dose syringe) for the emergency treatment of allergic reactions (Type I) including anaphylaxis.
Genentech, a member of the Roche Group announced that the FDA approved the Lucentis (ranibizumab injection) 0.3 mg prefilled syringe...
Global biotechnology leader CSL Behring announced the FDA approved a 50mL/10gm prefilled syringe for Hizentra (Immune Globulin Subcutaneous [Human] 20% Liquid)
Genentech, a member of the Roche Group announced that the FDA approved the Lucentis (ranibizumab injection) 0.5 mg prefilled syringe...
UCB and Ferring Pharmaceuticals Inc. announced they have entered into a co-promotion agreement to commercialize the prefilled syringe formulation of Cimzia (certolizumab pegol) in the United States, specifically for the treatment of Crohn’s disease (CD).
The FDA has accepted for review Adamis Pharmaceuticals New Drug Application for its Epinephrine Pre-filled Syringe product candidate for the...
The purpose of this study is to evaluate the serum concentration of ixekizumab after administration using either prefilled syringe or auto-injector in participants with moderate to severe plaque psoriasis.
Takeda announced the FDA approval of the Takhzyro (lanadelumab-flyo) injection single-dose prefilled syringe (PFS) to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.
Adamis Pharma files NDA at FDA for Adamis Pharmaceuticals Corporation announced the submission of a New Drug Application (NDA) to...
Genentech, a member of the Roche Group announced that the FDA has approved the company’s supplemental Biologics License Application for Xolair (omalizumab) prefilled syringe for self-injection across all approved U.S. indications.